Global Glaucoma-Epidemiology Market Forecast to 2026: Ken Research

0


Glaucoma is a common, asymptomatic group of eye diseases that causes damage to the eye’soptic nerve, resulting in progressive, irreversible vision loss. Glaucoma is one of the leading causes of blindness worldwide, especially in elderly people. Glaucoma is generally categorized as open-angle glaucoma (OAG), angle-closure glaucoma (ACG), or secondary glaucoma (SG), though other less common types exist. OAG and ACG can be classified as primary (primary open-angle glaucoma [POAG] or primary angle-closure glaucoma [PACG], respectively) or SG, depending on the cause.

To forecast the total prevalent cases of POAG, PACG, NTG, PPG, and SG in the 7MM, Global Data epidemiologists selected nationally representative, population-based studies that provided these epidemiological data in the 7MM. Global Data epidemiologists obtained data for the diagnosed prevalent cases of PPG from primary market research and authentic secondary sources. In addition, the forecast is supported by robust, country-specific data that were obtained from various authentic sources, such as research articles published in peer-reviewed journals.

In the 7MM, the total prevalent cases of POAG will increase from 7,224,135 cases in 2016 to 8,549,547 cases in 2026, at an Annual Growth Rate (AGR) of 1.83%. In the 7MM, the total prevalent cases of PACG will increase from 2,644,012 cases in 2016 to 3,124,740 cases in 2026, at an AGR of 1.82%. Global Data forecasts that all markets will see an increase in the total prevalent cases and diagnosed prevalent cases of POAG and PACG during the forecast period.

The Glaucoma EpiCast Report provides an overview of the risk factors and global trends of glaucoma in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the total prevalent cases and diagnosed prevalent cases of primary open-angle glaucoma (POAG) or primary angle-closure glaucoma (PACG), segmented by sex and age (40-49 years, 50-59 years, 60-69 years, 70-79 years, and ages 80 years and older) in these markets. In addition, this report provides a 10-year epidemiological forecast for the total prevalent cases and diagnosed prevalent cases of glaucoma clinical types normal-tension glaucoma (NTG), pre perimetric glaucoma (PPG), and secondary glaucoma (SG). The report also includes the diagnosed incident cases of acute PACG. The glaucoma epidemiology report is written and developed by Masters- and PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Key Topics Covered in the Report:

Global Glaucoma-Epidemiology Market Forecast

Global Glaucoma-Epidemiology Market Size

Global Glaucoma-Epidemiology Market Trends

Global Glaucoma-Epidemiology Market Outlook

Global Glaucoma-Epidemiology Market Share

Global Glaucoma-Epidemiology Market Revenue

Global Glaucoma-Epidemiology Market Volume

Global Glaucoma-Epidemiology Market Value

Global Glaucoma-Epidemiology Market

Global Glaucoma-Epidemiology Market Analysis

To know more, click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/epicast-report-glaucoma-epidemiology-forecast/142684-91.html

Contact:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91-124-4230204

Share.

Comments are closed.